Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF COMMON STOCK PURCHASE OPTIONS (Details)

v3.24.1.1.u2
SCHEDULE OF COMMON STOCK PURCHASE OPTIONS (Details)
9 Months Ended
Mar. 31, 2024
USD ($)
$ / shares
shares
Share-Based Payment Arrangement [Abstract]  
Number of shares options outstanding, beginning shares | shares
Number of shares options exercisable, beginning shares | shares
Weighted average exercise price options outstanding, beginning balance | $ / shares
Weighted average exercise price option exercisable, beginning balance | $ / shares
Number of shares options granted, shares | shares 250,000
Weighted average exercise price options granted | $ / shares $ 2.15
Weighted average remaining life in years granted 8 months 26 days
Number of shares options exercised, shares | shares
Weighted average exercise price options exercised | $ / shares
Number of shares options expired/cancelled, shares | shares
Weighted average exercise price options expired/cancelled | $ / shares
Number of shares options outstanding, ending shares | shares 250,000
Number of shares options exercisable, ending shares | shares 250,000
Weighted average exercise price options outstanding, ending balance | $ / shares $ 2.15
Weighted average exercise price option exercisable, ending balance | $ / shares $ 2.15
Weighted average remaining life in years outstanding 8 months 26 days
Weighted average remaining life in years exercisable 8 months 26 days
Aggregate intrinsic value outstanding | $ $ 155,000
Aggregate intrinsic value exercisable | $ $ 155,000